Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis
journal contributionposted on 04.11.2021, 16:53 authored by James O'DonnellJames O'Donnell, Flora Peyvandi, Ignacio Martin-Loeches
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is responsible for coronavirus disease 2019 (COVID-19). Recent data highlight a pivotal role for pulmonary immuno-thrombosis in COVID-19 in the pathogenesis of severe COVID-19.
Health Research Board COVID-19 Rapid Response award (COV19-2020-086)
3M Foundation to RCSI University of Medicine and Health Sciences in support of COVID-19 research
National Children’s Research Centre Project Award (C/18/1)
Italian Ministry of Health—Bando Ricerca Corrente
Italian fiscal contribution "5x1000" 2017 devolved to Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
Science Foundation Ireland, Enterprise Ireland, IDA Ireland COVID-19 Rapid Response award (20/COV/0038)
CommentsThe original article is available at https://link.springer.com
Published CitationO'Donnell JS, Peyvandi F, Martin-Loeches I. Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis. Intensive Care Med. 2021;47(8):899-902.
Publication Date30 May 2021
- Irish Centre for Vascular Biology
- School of Pharmacy and Biomolecular Sciences
- Vascular Biology
- Published Version (Version of Record)